Plasmodium berghei: combining folic acid antagonists for potentiation against malaria infections in mice.
D062365:Aminobenzoates / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D001769:Blood / Q000469:parasitology; D004338:Drug Combinations; D004357:Drug Synergism; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D008288:Malaria / Q000188:drug therapy* / Q000469:parasitology; D051379:Mice; D009282:Naphthalenesulfonates / Q000627:therapeutic use; D010962:Plasmodium berghei; D011799:Quinazolines / Q000627:therapeutic use; D013411:Sulfadiazine / Q000037:antagonists & inhibitors / Q000627:therapeutic use
D062365:Aminobenzoates; D000962:Antimalarials; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D009282:Naphthalenesulfonates; D011799:Quinazolines; D013411:Sulfadiazine